Showing results (101-110 of 1,205) with videos related to
Sort By:
Pageof 121
Liver International : Official Journal of the International Association for the Study of the Liver|September 12, 2007
Extrahepatic cholestasis downregulates Oatp1 by TNF-alpha signalling without affecting Oatp2 and Oatp4 expression and sodium-independent bile salt uptake in rat liverAndreas Geier, Christoph G Dietrich, Michael Trauner, et al.Best Practice & Research. Clinical Gastroenterology|November 29, 2011
Pathogenesis of primary sclerosing cholangitisMarion J Pollheimer, Emina Halilbasic, Peter Fickert, et al.Hepatic Medicine : Evidence and Research|November 22, 2017
PNPLA3 expression and its impact on the liver: current perspectivesFrancesca Virginia Bruschi, Matteo Tardelli, Thierry Claudel, et al.Gastroenterology|September 2, 2003
Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated miceMartin Wagner, Peter Fickert, Gernot Zollner, et al.Digestive Diseases (Basel, Switzerland)|December 8, 2015
Therapy of Primary Sclerosing Cholangitis--Today and TomorrowEmina Halilbasic, Claudia Fuchs, Harald Hofer, et al.Gastroenterology|February 14, 2006
24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout micePeter Fickert, Martin Wagner, Hanns-Ulrich Marschall, et al.Genes|April 30, 2021
The Role of Lipid Sensing Nuclear Receptors (PPARs and LXR) and Metabolic Lipases in Obesity, Diabetes and NAFLDEmmanuel D Dixon, Alexander D Nardo, Thierry Claudel, et al.Digestion|September 9, 2014
Alterations of canalicular ATP-binding cassette transporter expression in drug-induced liver injuryGernot Zollner, Andrea Thueringer, Carolin Lackner, et al.Journal of Hepatology|October 15, 2005
Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genesYury Popov, Eleonora Patsenker, Peter Fickert, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 29, 2017
Management of portal hypertension before and after liver transplantationLukas W Unger, Gabriela A Berlakovich, Michael Trauner, et al.Pageof 121